Submission Deadline: March 1, 2026, Midnight EST

Purpose of Scientific Papers

Scientific Papers present original research, clinical investigations, or data-driven case studies relevant to equine veterinary practice. Submissions are welcome from all areas of equine medicine and surgery. Priority will be given to papers that offer practical application or present new information.

Submissions must contain complete data and analysis. Incomplete studies, proposed methods without results, or preliminary findings are not eligible for acceptance.  At least one author must be a veterinarian for any report involving diagnosis, treatment, or medical interpretation.

For those intending to publish in a peer-reviewed journal, use the Abbreviated Abstract submission process.

Presentation Format

Presentations are limited to 15 minutes, followed by 5 minutes for Q&A.

- Manuscriptsmust be a minimum of 600 words.
- There is no maximum word count.
- Papers must follow the formatting requirements outlined in the General Guidelines.

Required Section Headings

Scientific Papers should include the following core sections:

Paper Title
* Title should be concise, descriptive, and formatted in title case (capitalize key words).
* Avoid unnecessary punctuation or sentence-style phrasing.
- Good: Intra-Articular Therapies for Managing Coxofemoral Osteoarthritis in Horses
- Not Ideal: This paper explores how intra-articular therapies can help manage coxofemoral osteoarthritis in horses

Take-Home Message
* A short summary (1–3 sentences; approximately 50 words) that communicates the practical application or significance of the findings.
* Should clearly express practical application for the equine practitioner.
* Take-Home Message Example: There are multiple upper respiratory conditions that impact performance during high-speed exercise. Differentiating between these allows for targeted treatment and improved outcomes.
* This section is included in the word count.

Introduction
* Briefly introduce the topic, referencing relevant prior research.
* Include the clinical significance and rationale for the study.
* End with a clear statement of objectives or hypotheses.

Materials and Methods
* Describe the study design, animal population, inclusion criteria, procedures, and data collection methods.
* Include detailed descriptions of statistical analysis: methods, normality testing, and parametric or nonparametric choices.
* Use metric units for all dosages, weights, and measurements.
- Correct: 22 mg/kg, q 12 h, IV
- Incorrect: 10 mg/lb, BID, IV

Results
* Present actual findings, including numerical data.
* State number of horses included.
* Provide descriptive statistics (mean, median, SD, SE, confidence intervals) and hypothesis test results.
* Tables or figures may be used if they aid interpretation.

Discussion
* Interpret results and compare with existing literature.
* Discuss potential reasons for agreement or discrepancy.
* Clearly define clinical relevance, including estimated population affected and safety and efficacy if applicable.
* End with a summary that reflects and reinforces the Take-Home Message.

Acknowledgments
* i. Declaration of Ethics
* ii. Conflicts of Interest
* iii. Funding/Material/Technical Support
(See General Guidelines for formatting requirements.)

References
* Use Vancouver style, as per JAVMA citation standards.
* Number citations in the text using superscripts, in the order they appear.
* See General Guidelines for detailed formatting requirements.
* Authors are responsible for ensuring formatting and accuracy of all citations.

For help with reference formatting please google “Vancouver citation tutorial” or check this link with a roughly 3-minute video: Bing Videos.

Blinded Review Policy

To ensure an unbiased review process, all submitted papers must be blinded. See General Guidelines for detailed blinding requirements. Submissions will be reviewed by a blinded team from the Scientific Review &Editorial Committee (SREC) for relevance, clarity, and value to equine practitioners.

Please consult the General Guidelines for additional details on formatting, ethical disclosures, compounded medications, permissions, and submission policies.